Insights into novel emerging epigenetic drugs in myeloid malignancies

por Chandhok, Namrata S., Prebet, Thomas
Publicado 2019

Emerging treatment options for patients with high-risk myelodysplastic syndrome

por Bewersdorf, Jan Philipp, Carraway, Hetty, Prebet, Thomas
Publicado 2020

Current challenges and unmet medical needs in myelodysplastic syndromes

por Platzbecker, Uwe, Kubasch, Anne Sophie, Homer-Bouthiette, Collin, Prebet, Thomas
Publicado 2021

Definition of Personalized Medicine and Targeted Therapies: Does Medical Familiarity Matter?

por Fournier, Valentyn, Prebet, Thomas, Dormal, Alexandra, Brunel, Maïté, Cremer, Robin, Schiaratura, Loris
Publicado 2021

Epigenetics in Cancer: A Hematological Perspective

por Stahl, Maximilian, Kohrman, Nathan, Gore, Steven D., Kim, Tae Kon, Zeidan, Amer M., Prebet, Thomas
Publicado 2016

Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysi...

por Cortes, Jorge E., Lin, Tara L., Asubonteng, Kobby, Faderl, Stefan, Lancet, Jeffrey E., Prebet, Thomas
Publicado 2022

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity

por Chretien, Anne-Sophie, Le Roy, Aude, Vey, Norbert, Prebet, Thomas, Blaise, Didier, Fauriat, Cyril, Olive, Daniel
Publicado 2014

Comprehensive Clinicopathologic and Molecular Analysis of Mast Cell Leukemia With Associated Hematologic Neoplasm: A Report and In-Depth Study of 5 Cases

por Li, Philippa, Biancon, Giulia, Patel, Timil, Pan, Zenggang, Kothari, Shalin, Halene, Stephanie, Prebet, Thomas, Xu, Mina L.
Publicado 2021

An essential pathway links FLT3-ITD, HCK and CDK6 in acute myeloid leukemia

por Lopez, Sophie, Voisset, Edwige, Tisserand, Julie C., Mosca, Cyndie, Prebet, Thomas, Santamaria, David, Dubreuil, Patrice, Sepulveda, Paulo De
Publicado 2016

PB2014: A PHASE 2/3 TRIAL OF ORAL AZACITIDINE IN PATIENTS WITH LOW- OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROMES

por Garcia-Manero, Guillermo, Santini, Valeria, Fenaux, Pierre, Suzuki, Takahiro, Sekeres, Mikkael, He, Jun, Barkalifa, Ronit, Vigil, Carlos, Prebet, Thomas, Komrokji, Rami S., Giagounidis, Aristoteles
Publicado 2023

Therapeutic Targeting of c-Myc in T-Cell Acute Lymphoblastic Leukemia (T-ALL)

por Loosveld, Marie, Castellano, Rémy, Gon, Stéphanie, Goubard, Armelle, Crouzet, Thomas, Pouyet, Laurent, Prebet, Thomas, Vey, Norbert, Nadel, Bertrand, Collette, Yves, Payet-Bornet, Dominique
Publicado 2014

Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record datab...

por Zeidan, Amer M., Pollyea, Daniel A., Borate, Uma, Vasconcelos, Alberto, Potluri, Ravi, Rotter, David, Kiendrebeogo, Zephirin, Gaugler, Lona, Prebet, Thomas, Strocchia, Maria, Bonifacio, Gaetano, Chen, Clara
Publicado 2023

Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medic...

por Zeidan, Amer M., Pollyea, Daniel A., Borate, Uma, Vasconcelos, Alberto, Potluri, Ravi, Rotter, David, Kiendrebeogo, Zephirin, Gaugler, Lona, Prebet, Thomas, Strocchia, Maria, Bonifacio, Gaetano, Chen, Clara
Publicado 2023

Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

por Prebet, Thomas, Toma, Andrea, Cluzeau, Thomas, Sekeres, Mikkael A., Vey, Norbert, Park, Sophie, Al Ali, Najla, Sugrue, Marie M., Komrokji, Rami, Fenaux, Pierre, Gore, Steven D.
Publicado 2017

A phase 1 study of the pan‐bromodomain and extraterminal inhibitor mivebresib (ABBV‐075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid...

por Borthakur, Gautam, Odenike, Olatoyosi, Aldoss, Ibrahim, Rizzieri, David A., Prebet, Thomas, Chen, Chris, Popovic, Relja, Modi, Dimple A., Joshi, Rujuta H., Wolff, Johannes E., Jonas, Brian A.
Publicado 2021

Therapy-related acute myeloid leukemia following treatment of lymphoid malignancies

por Bertoli, Sarah, Sterin, Arthur, Tavitian, Suzanne, Oberic, Lucie, Ysebaert, Loïc, Bouabdallah, Reda, Vergez, François, Sarry, Audrey, Bérard, Emilie, Huguet, Françoise, Laurent, Guy, Prébet, Thomas, Vey, Norbert, Récher, Christian
Publicado 2016

P567: PHASE 1B OMNIVERSE TRIAL: SAFETY AND TOLERABILITY OF ORAL AZACITIDINE IN COMBINATION WITH VENETOCLAX FOR TREATMENT OF ACUTE MYELOID LEUKEMIA

por Fleming, Shaun, Roboz, Gail, T. Fathi, Amir, Y. Zhang, Tian, Wei, Andrew, Carraway, Hetty, Holes, Leanne, Petrlik, Erica, Prebet, Thomas, Lopes De Menezes, Daniel, Bluemmert, Iryna, Sun, Hao, Ravandi, Farhad
Publicado 2023

Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase III QU...

por Wei, Andrew H., Roboz, Gail J., Dombret, Hervé, Döhner, Hartmut, Schuh, Andre C., Montesinos, Pau, Selleslag, Dominik, Bondarenko, Sergey N., Prebet, Thomas, Lai, Yinzhi, Skikne, Barry, Beach, C.L., Ravandi, Farhad
Publicado 2023

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes

por Devillier, Raynier, Mansat-De Mas, Véronique, Gelsi-Boyer, Veronique, Demur, Cecile, Murati, Anne, Corre, Jill, Prebet, Thomas, Bertoli, Sarah, Brecqueville, Mandy, Arnoulet, Christine, Recher, Christian, Vey, Norbert, Mozziconacci, Marie-Joelle, Delabesse, Eric, Birnbaum, Daniel
Publicado 2015

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre‐leukaemic clone resulting in T2‐ALL and AML‐M0

por Manchev, Vladimir T., Bouzid, Hind, Antony‐Debré, Iléana, Leite, Betty, Meurice, Guillaume, Droin, Nathalie, Prebet, Thomas, Costello, Régis T., Vainchenker, William, Plo, Isabelle, Diop, M'boyba, Macintyre, Elizabeth, Asnafi, Vahid, Favier, Rémi, Baccini, Véronique, Raslova, Hana
Publicado 2016